About
Emedgene is a genomics intelligence platform that uses natural language processing to digest new genetic publications and incorporate them into an always-up-to-date knowledge base. It then runs machine-learning discovery algorithms to pinpoint pathogenic variants for a clear path to clinical decisions. Clinical labs using Emedgene can improve dry lab efficiency, reduce time spent on interpretation and reporting, increase yield, and scale up their genomic interpretation operation. Research organizations using Emedgene can accelerate genomic-driven discovery through the application of end-to-end artificial intelligence, from natural language processing of publications through custom machine-learning algorithms. Emedgene aims to help geneticists and clinicians understand the clinical meaning of unique genetic variants so that they can provide their patients with personalized care.
Funding history · 2 rounds · $6.0M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Emedgene's primary focus?
- Emedgene is an AI-based platform for automated genomic interpretation, utilizing natural language processing and machine learning to analyze genetic publications and identify pathogenic variants for clinical decisions.
- When was Emedgene founded?
- Emedgene was founded in April 2015.
- What is Emedgene's current operational status?
- Emedgene is currently inactive, having been acquired by Illumina in December 2021.
- How much total funding did Emedgene raise before its acquisition?
- Emedgene raised a total of $6,019,000 in funding. For a full financing history, please refer to startupim.
- Which investor led Emedgene's Series A funding round?
- OTV led Emedgene's Series A funding round in February 2019.
- When did Emedgene receive a grant from the IIA?
- Emedgene received a grant of $19,000 from the IIA in October 2018.
- Where are Emedgene's main offices located?
- Emedgene has its headquarters in Tel Aviv-Yafo, Israel, and an additional office in Palo Alto, California, USA.
- How many employees did Emedgene have?
- Emedgene had approximately 11-50 employees, with an exact count of 32.
- What was a key partnership for Emedgene before its acquisition?
- In December 2020, Emedgene collaborated with Illumina to scale the interpretation of genomic data for rare diseases.